After upbeat earnings and accepted Leucadia offer, we can still see company's share dropping and Credit Suisse holding it as 'Underperform,'KBW's downgrade of the company as well, just added to the sell-off. What is wrong with the stock? Albeit some positive may be seen in Leucadia's steps, we can see lower value for public shareholders as most of it goes to Leucadia. Moreover, 40% drop in trading volume during February is not helping the outlook of FXCM as well. From Friday's nearly $2.8 price a 20% drop is seen due to poor expectations.